Your session is about to expire
← Back to Search
Other
Bipolar Disorder for Bipolar Disorder (BIPO Trial)
N/A
Recruiting
Led By Nicolaas Bohnen, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 90 +/- 10 days of intervention
Awards & highlights
BIPO Trial Summary
"This trial is looking at whether a supplement called Juvenescence, combined with a diet that mimics the effects of the ketogenic diet, could help people with bipolar disorder. It is a small study
BIPO Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 90 +/- 10 days of intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 90 +/- 10 days of intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in blood beta-hydroxybutyrate level
Secondary outcome measures
Change in blood glucose lability
Change in neural network stability
BIPO Trial Design
1Treatment groups
Experimental Treatment
Group I: Bipolar DisorderExperimental Treatment2 Interventions
Participants will follow an intervention consisting of dietary changes and ketone ester supplementation for 90 +/- 10 days. The dietary changes are intended to reduce glycemic spiking and include: not consuming sweets, not consuming soda, replacing 'white' grains with whole grain alternatives, and reserving any fruit consumption for the end of meals. During the same time period, participants will consume the ketone ester supplement, consisting of 19 g Juvenescence Cognitive Switch™ (=12.5 g active C8-KE) diluted in water twice per day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Glycemic Index Diet
2014
N/A
~290
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,812 Previous Clinical Trials
6,384,787 Total Patients Enrolled
19 Trials studying Bipolar Disorder
3,202 Patients Enrolled for Bipolar Disorder
Nicolaas Bohnen, MDPrincipal InvestigatorUniversity of Michigan
2 Previous Clinical Trials
30 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger